Covered recipient · General Payments record
KARRI ANN ERDMANN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,504.03
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $844.20 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $436.78 | 15 |
| Galderma Laboratories, L.P. | $187.62 | 2 |
| REVANCE THERAPEUTICS, INC. | $152.04 | 4 |
| Incyte Corporation | $23.34 | 1 |
| Arcutis Biotherapeutics, Inc. | $23.20 | 1 |
| MERZ NORTH AMERICA, INC. | $21.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $116.21 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107076510 | CMS |
| ABBVIE INC. | $6.93 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107076512 | CMS |
| ABBVIE INC. | $13.50 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107076514 | CMS |
| ABBVIE INC. | $5.60 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107076516 | CMS |
| ABBVIE INC. | $14.49 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107076518 | CMS |
| ABBVIE INC. | $4.43 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107076520 | CMS |
| ABBVIE INC. | $13.06 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107076522 | CMS |
| ABBVIE INC. | $15.88 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107076524 | CMS |
| ABBVIE INC. | $15.22 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107076526 | CMS |
| ABBVIE INC. | $14.72 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107076528 | CMS |
| ABBVIE INC. | $14.72 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107076530 | CMS |
| ABBVIE INC. | $18.12 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107076532 | CMS |
| ABBVIE INC. | $16.04 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107076534 | CMS |
| ABBVIE INC. | $148.49 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107076536 | CMS |
| ABBVIE INC. | $19.37 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107076538 | CMS |
| Arcutis Biotherapeutics, Inc. | $23.20 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121103632 | CMS |
| Galderma Laboratories, L.P. | $164.44 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145356167 | CMS |
| Galderma Laboratories, L.P. | $23.18 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145356169 | CMS |
| Incyte Corporation | $23.34 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141182810 | CMS |
| MERZ NORTH AMERICA, INC. | $21.22 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146386189 | CMS |
| REVANCE THERAPEUTICS, INC. | $32.24 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147938861 | CMS |
| REVANCE THERAPEUTICS, INC. | $40.49 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147938863 | CMS |
| REVANCE THERAPEUTICS, INC. | $32.28 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147938865 | CMS |
| REVANCE THERAPEUTICS, INC. | $47.03 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147938867 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.